Morgan Stanley’s Confidence Rises in American Healthcare REIT (AHR) Following Senior Housing Review

Core Insights - American Healthcare REIT, Inc. (NYSE:AHR) is recognized as one of the 14 best up-and-coming dividend stocks to buy [1] - Morgan Stanley has increased its price target for AHR to $55 from $52, maintaining an Overweight rating, indicating growing confidence in the company's performance in the senior housing sector [2] - For Q3 2025, AHR reported a GAAP net income of $55.9 million, or $0.33 per diluted share, with same-store NOI increasing by 16.4% [3] - The company has been active in acquisitions, closing approximately $210.8 million in deals during the quarter and over $575 million year-to-date [3] - AHR has partnered with WellQuest Living and has a development pipeline projected to cost around $177 million [4] - The company raised its full-year 2025 normalized FFO guidance to a range of $1.69 to $1.72 per diluted share, up from a previous range of $1.64 to $1.68, reflecting better-than-expected organic growth [4] - AHR focuses on healthcare real estate, particularly in senior housing, skilled nursing facilities, and outpatient medical properties across the US, UK, and Isle of Man [5]